Immunocore Holdings plc (IMCR)

NASDAQ: IMCR · Real-Time Price · USD

36.02

+0.97 (2.77%)

At close: Aug 18, 2026, 4:00 PM EDT

36.20

+0.18 (0.50%)

After-hours: Aug 18, 2026, 5:56 PM EDT

Immunocore Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	430.78	400.02	310.2	249.43	174.36	36.48
Revenue	430.78	400.02	310.2	249.43	174.36	36.48
Revenue Growth	20.95%	28.95%	24.37%	43.05%	377.91%	-11.26%
Cost of Revenue	289.19	279.96	224.88	164.58	6.4	100.25
Gross Profit	141.59	120.06	85.32	84.85	167.96	-63.76
Selling, General & Admin	164.16	165.41	155.78	144.5	123.06	110.82
Research & Development	-	-	-	-	96.61	-
Other Operating Expenses	-19.73	-19.73	-18.05	0.9	-0.01	0.07
Operating Expenses	144.44	145.69	137.73	145.39	219.66	110.9
Operating Income	-2.85	-25.63	-52.41	-60.55	-51.7	-174.66
Interest Expense	-12.21	-12.17	-18.84	-5.15	-5.41	-5.57
Interest & Investment Income	15.03	16.48	25.62	17.99	3.76	0.07
Currency Exchange Gain (Loss)	2.61	2.22	-3.45	-13.18	14.16	0.29
EBT Excluding Unusual Items	2.58	-19.1	-49.08	-60.89	-39.2	-179.88
Gain (Loss) on Sale of Investments	-5.32	-	-	-	-	-
Other Unusual Items	-	-	-3.85	-	-1.69	-
Pretax Income	-2.73	-19.1	-52.94	-60.89	-40.88	-179.88
Income Tax Expense	15.34	16.41	-1.85	-5.6	11.66	0.15
Net Income	-18.07	-35.51	-51.09	-55.29	-52.54	-180.03
Net Income to Common	-18.07	-35.51	-51.09	-55.29	-52.54	-180.03
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	51	50	50	49	46	42
Shares Outstanding (Diluted)	51	50	50	49	46	42
Shares Change	1.14%	0.71%	2.25%	6.94%	7.59%	60.19%
EPS (Basic)	-0.36	-0.71	-1.02	-1.13	-1.15	-4.24
EPS (Diluted)	-0.36	-0.71	-1.02	-1.13	-1.15	-4.24
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-41.15	-15.05	20.89	-2.49	-51.41	-144.49
Free Cash Flow Per Share	-0.81	-0.30	0.42	-0.05	-1.13	-3.40
Gross Margin	32.87%	30.01%	27.51%	34.02%	96.33%	-174.77%
Operating Margin	-0.66%	-6.41%	-16.89%	-24.27%	-29.65%	-478.73%
Profit Margin	-4.20%	-8.88%	-16.47%	-22.17%	-30.14%	-493.45%
Free Cash Flow Margin	-9.55%	-3.76%	6.73%	-1.00%	-29.49%	-396.04%
EBITDA	0.76	-22.36	-48.21	-56.46	-46.37	-167.07
EBITDA Margin	0.18%	-5.59%	-15.54%	-22.63%	-26.59%	-
D&A For EBITDA	3.61	3.27	4.2	4.09	5.34	7.59
EBIT	-2.85	-25.63	-52.41	-60.55	-51.7	-174.66
EBIT Margin	-0.66%	-6.41%	-16.89%	-24.27%	-29.65%	-
Revenue as Reported	430.78	400.02	310.2	249.43	174.36	36.48

SEC Filings: 10-K · 10-Q